December 11, 2025 18:22 ET | Source: Mesoblast Limited NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;…
Media Release Event to be held virtually via live webcast and archived on www.genmab.com Copenhagen, Denmark; December 11, 2025 – Genmab…
93% overall response and 76% complete response rates with median progression-free survival of 18 months in patients with large B-cell…
December 06, 2025 17:30 ET | Source: TScan Therapeutics, Inc. Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23)…
December 06, 2025 17:30 ET | Source: Fulcrum Therapeutics, Inc. ― Clear dose-response observed, with a robust and clinically meaningful…
26 November 2025 - The International Olympic Committee (IOC) Executive Board (EB) will hold its final meeting of 2025 on 9 and…
Data spans five abstracts including two oral presentations with important findings for patients living with blastic plasmacytoid dendritic cell neoplasm (BPDCN)BPDCN…
November 24, 2025 02:00 ET | Source: DXS International PLC Monday 24 November DXS INTERNATIONAL PLC (AQSE: DXSP) Notice of…
Obagi® saypha® ChIQ™ data selected as a top 10 cosmetic oral abstract presentation November 16, 2025 01:02 ET | Source:…
November 12, 2025 18:03 ET | Source: Aurora Spine Corporation Company to Showcase Cutting-Edge Innovations at Booth #1622 CARLSBAD, Calif.,…